2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation

H Calkins, G Hindricks, R Cappato, YH Kim… - Ep …, 2018 - academic.oup.com
AFL atrial flutter AH arterial hypertension ANS autonomic nervous system APD action
potential duration ARREST-AF Aggressive Risk Factor Reduction Study for Atrial Fibrillation …

[PDF][PDF] 2018 Korean guideline of atrial fibrillation management

B Joung, JM Lee, KH Lee, TH Kim… - Korean circulation …, 2018 - synapse.koreamed.org
Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia in the general
population. The Korean Heart Rhythm Society organized a Korean AF Management …

Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation

H Heidbuchel, P Verhamme, M Alings, M Antz… - Ep …, 2015 - academic.oup.com
The current manuscript is an update of the original Practical Guide, published in June 2013
[Heidbuchel H, Verhamme P, Alings M, Antz M, Hacke W, Oldgren J, et al. European Heart …

[HTML][HTML] Uninterrupted dabigatran versus warfarin for ablation in atrial fibrillation

H Calkins, S Willems, EP Gerstenfeld… - … England Journal of …, 2017 - Mass Medical Soc
Background Catheter ablation of atrial fibrillation is typically performed with uninterrupted
anticoagulation with warfarin or interrupted non–vitamin K antagonist oral anticoagulant …

Left atrial appendage isolation in patients with longstanding persistent AF undergoing catheter ablation: BELIEF trial

L Di Biase, JD Burkhardt, P Mohanty, S Mohanty… - Journal of the American …, 2016 - jacc.org
Background: Longstanding persistent (LSP) atrial fibrillation (AF) is the most challenging
type of AF. In addition to pulmonary vein isolation, substrate modification and triggers …

Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary or valve …

Task Force Members, GYH Lip… - European heart …, 2014 - academic.oup.com
Atrial fibrillation (AF) confers a substantial risk of mortality and morbidity from stroke and
thrombo-embolism, and this common cardiac arrhythmia represents a major healthcare …

[PDF][PDF] 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS

F Casselman, A Coca, R De Caterina… - European heart …, 2016 - academia.edu
Surveys and registries are needed to verify that real-life daily practice is in kee** with what
is recommended in the guidelines, thus completing the loop between clinical research …

Uninterrupted rivaroxaban vs. uninterrupted vitamin K antagonists for catheter ablation in non-valvular atrial fibrillation

R Cappato, FE Marchlinski, SH Hohnloser… - European heart …, 2015 - academic.oup.com
Aims VENTURE-AF is the first prospective randomized trial of uninterrupted rivaroxaban and
vitamin K antagonists (VKAs) in patients with non-valvular atrial fibrillation (NVAF) …

Periprocedural stroke and bleeding complications in patients undergoing catheter ablation of atrial fibrillation with different anticoagulation management: results from …

L Di Biase, JD Burkhardt, P Santangeli, P Mohanty… - Circulation, 2014 - Am Heart Assoc
Background—Periprocedural thromboembolic and hemorrhagic events are worrisome
complications of catheter ablation for atrial fibrillation (AF). The periprocedural …

2014 focused update of the Canadian Cardiovascular Society Guidelines for the management of atrial fibrillation

A Verma, JA Cairns, LB Mitchell, L Macle… - Canadian Journal of …, 2014 - Elsevier
Atrial fibrillation (AF) is an extremely common clinical problem with an important population
morbidity and mortality burden. The management of AF is complex and fraught with many …